Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study.
Davide Fiore BavaroNicolò De GennaroAlessandra BelatiLucia DiellaRoberta PapagniLuisa FrallonardoMichele CamporealeGiacomo GuidoCarmen PellegrinoMaricla MarroneAlessandro Dell'ErbaLoreto GesualdoNicola BrienzaSalvatore GrassoGiuseppe ColumboAntonio MoschettaGiovanna Elisiana CarpagnanoAntonio DalenoAnna Maria MinicucciGiovanni MiglioreAnnalisa SaracinoPublished in: Antibiotics (Basel, Switzerland) (2023)
Implementation of AS and DS intervention through a pro-active ID consultation may reduce the risk of 28-day mortality of COVID-19 patients with MDROs infections.
Keyphrases
- coronavirus disease
- sars cov
- multidrug resistant
- infectious diseases
- palliative care
- healthcare
- gram negative
- randomized controlled trial
- anti inflammatory
- primary care
- respiratory syndrome coronavirus
- acinetobacter baumannii
- drug resistant
- cardiovascular events
- risk factors
- quality improvement
- cystic fibrosis
- coronary artery disease
- klebsiella pneumoniae
- adverse drug
- electronic health record
- drug induced